Latest news
2026-08-09 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Reach Out | NDAQ:CAPR | Press Release - stockhouse.comstockhouse.com · Sun, 09 Aug 2026 17:00:00 GMTBronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-DemocratCarroll County Mirror-Democrat · Sun, 09 Aug 2026 16:00:00 GMTKaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (N - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 23:10:09 GMTCAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.comaccessnewswire.com · Sat, 08 Aug 2026 04:23:41 GMTCapricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR - PR NewswirePR Newswire · Sat, 08 Aug 2026 02:00:00 GMTCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 19:26:00 GMTTangible book value per share of Capricor Therapeutics, Inc. – HAM:4LN2 - TradingViewTradingView · Fri, 07 Aug 2026 18:10:32 GMTCAPR Shareholder Alert: Investors With Losses May Seek to - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 14:08:00 GMT